- Home
- CMMB vs ADD Comparison
CMMB vs ADD Comparison
Compare CMMB & ADD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- ADD
- Stock Information
- Founded
- CMMB 2004
- ADD 2002
- Country
- CMMB Israel
- ADD United States
- Employees
- CMMB N/A
- ADD N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- ADD Engineering & Construction
- Sector
- CMMB Health Care
- ADD Consumer Discretionary
- Exchange
- CMMB Nasdaq
- ADD Nasdaq
- Market Cap
- CMMB 22.0M
- ADD 25.4M
- IPO Year
- CMMB N/A
- ADD N/A
- Fundamental
- Price
- CMMB $1.13
- ADD $0.95
- Analyst Decision
- CMMB Strong Buy
- ADD
- Analyst Count
- CMMB 2
- ADD 0
- Target Price
- CMMB $8.50
- ADD N/A
- AVG Volume (30 Days)
- CMMB 187.2K
- ADD 417.0K
- Earning Date
- CMMB 08-20-2025
- ADD 06-25-2025
- Dividend Yield
- CMMB N/A
- ADD N/A
- EPS Growth
- CMMB N/A
- ADD N/A
- EPS
- CMMB N/A
- ADD N/A
- Revenue
- CMMB N/A
- ADD $1,770,000.00
- Revenue This Year
- CMMB N/A
- ADD N/A
- Revenue Next Year
- CMMB N/A
- ADD N/A
- P/E Ratio
- CMMB N/A
- ADD N/A
- Revenue Growth
- CMMB N/A
- ADD 66.91
- 52 Week Low
- CMMB $0.87
- ADD $0.56
- 52 Week High
- CMMB $2.55
- ADD $185.00
- Technical
- Relative Strength Index (RSI)
- CMMB 42.55
- ADD 52.50
- Support Level
- CMMB $1.17
- ADD $0.91
- Resistance Level
- CMMB $1.23
- ADD $1.05
- Average True Range (ATR)
- CMMB 0.05
- ADD 0.09
- MACD
- CMMB 0.00
- ADD 0.01
- Stochastic Oscillator
- CMMB 34.11
- ADD 66.67
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin, and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life-threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101, treating rare fibrotic conditions.
About ADD Color Star Technology Co. Ltd.
Color Star Technology Co Ltd is an entertainment technology company with a network that focuses on the application of technology and artificial intelligence in the entertainment industry. It provides online entertainment performances and online education through its wholly-owned subsidiaries Color Metaverse and CACM. The curriculum developed by the company includes music, sports, animation, painting and calligraphy, film and television, and life skills, covering various aspects of entertainment, sports, and culture.